Multiple short courses of corticosteroids in children

Tristan Harding1, Anton Harding2

  • 1BSc, MSc, MD, Paediatric Registrar, The Royal Children@s Hospital, Vic.

Insights

Short courses of oral corticosteroids are safe for children. Longer steroid use requires specialist management to prevent adrenal insufficiency and other side effects.

Area of Science:

  • Pediatric Endocrinology
  • Pharmacology
  • Immunology

Background:

  • Corticosteroids are vital adrenal hormones regulating immune homeostasis, blood pressure, and metabolism.
  • Oral corticosteroids are frequently prescribed for pediatric conditions like asthma and inflammatory bowel disease.
  • Concerns exist regarding potential side effects of steroid use, including growth reduction, weight gain, behavioral changes, and immunosuppression.

Purpose of the Study:

  • To provide an overview of oral corticosteroid use in common pediatric conditions.
  • To highlight current management strategies for pediatric steroid use.
  • To discuss the risks associated with recurrent corticosteroid dosing in children.

Main Methods:

  • Literature review of studies on pediatric corticosteroid use.
  • Analysis of current clinical guidelines and management practices.
  • Synthesis of data on short-term and long-term side effects.

Main Results:

  • Short-term oral corticosteroid courses (under two weeks) are unlikely to cause long-term adverse effects in children.
  • Prolonged corticosteroid therapy necessitates specialist referral and a carefully managed weaning plan.
  • Recurrent steroid courses may increase the risk of adrenal suppression and insufficiency.

Conclusions:

  • Judicious use of short-term corticosteroids is generally safe in pediatric populations.
  • Extended corticosteroid treatment requires vigilant monitoring and specialist input to mitigate risks.
  • Effective management strategies are crucial for minimizing adverse outcomes in children on long-term steroids.
Abstract

Related Concept Videos

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.3K
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
293
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
544
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
100
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
318
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
295